Telomere shortening over 6 years is associated with increased subclinical carotid vascular damage and worse cardiovascular prognosis in the general population

Journal of Internal Medicine

Volumn 277, Issue 4, 2015, Pages 478-487

  Baragetti, A ^a,b   Palmen, J ^c   Garlaschelli, K ^a   Grigore, L ^a,d   Pellegatta, F ^a,d   Tragni, E ^b   Catapano, A L ^b,d   Humphries, S E ^c   Norata, G D ^a,b,e   Talmud, P J ^c  

^a Bassini Hospital   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d IRCCS MULTIMEDICA   (Italy)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Ageing; Cardiovascular disease; Intima media thickness; Leucocytes telomere length; Telomere shortening

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; APOLIPOPROTEIN B; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

AGE; ALCOHOL CONSUMPTION; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY INJURY; CONTROLLED STUDY; DISEASE COURSE; DRUG USE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; LEUKOCYTE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; CAROTID ARTERY DISEASE; CHEMISTRY; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; TELOMERE;

CAROTID ARTERY DISEASES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; POLYMERASE CHAIN REACTION; PROGNOSIS; ROC CURVE; TELOMERE;

EID: 84925350896     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12282     Document Type: Article

References (50)

1. Armanios M, Blackburn EH. The telomere syndromes. Nat Rev Genet 2012; 13: 693-704.
2. Blackburn EH. Telomeres and telomerase: the means to the end (Nobel lecture). Angew Chem Int Ed Engl 2010; 49: 7405-21.
3. Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 2006; 12: 1133-8.
4. Armanios M. Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Invest 2013; 123: 996-1002.
5. Petersen S, Saretzki G, von Zglinicki T. Preferential accumulation of single-stranded regions in telomeres of human fibroblasts. Exp Cell Res 1998; 239: 152-60.
6. Serra V, Grune T, Sitte N, Saretzki G, von Zglinicki T. Telomere length as a marker of oxidative stress in primary human fibroblast cultures. Ann N Y Acad Sci 2000; 908: 327-30.
7. Longhese MP, Anbalagan S, Martina M, Bonetti D. The role of shelterin in maintaining telomere integrity. Front Biosci (Landmark Ed) 2012; 17: 1715-28.
8. Armanios M, Alder JK, Parry EM, Karim B, Strong MA, Greider CW. Short telomeres are sufficient to cause the degenerative defects associated with aging. Am J Hum Genet 2009; 85: 823-32.
9. Goldman F, Bouarich R, Kulkarni S et al. The effect of TERC haploinsufficiency on the inheritance of telomere length. Proc Natl Acad Sci USA 2005; 102: 17119-24.
10. Codd V, Nelson CP, Albrecht E et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet 2013; 45: 422-7, 7e1-2.
11. Moslehi J, DePinho RA, Sahin E. Telomeres and mitochondria in the aging heart. Circ Res 2012; 110: 1226-37.
12. Sahin E, DePinho RA. Axis of ageing: telomeres, p53 and mitochondria. Nat Rev Mol Cell Biol 2012; 13: 397-404.
13. Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 2003; 23: 842-6.
14. Brouilette SW, Moore JS, McMahon AD et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 2007; 369: 107-14.
15. Maubaret CG, Salpea KD, Jain A et al. Telomeres are shorter in myocardial infarction patients compared to healthy subjects: correlation with environmental risk factors. J Mol Med (Berl) 2010; 88: 785-94.
16. Norata GD, Garlaschelli K, Grigore L et al. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population. Nutr Metab Cardiovasc Dis 2009; 19: 129-34.
17. Norata GD, Garlaschelli K, Grigore L et al. Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE alleles. Atherosclerosis 2010; 208: 177-82.
18. Predazzi IM, Norata GD, Vecchione L et al. Association between OLR1 K167N SNP and intima media thickness of the common carotid artery in the general population. PLoS ONE 2012; 7: e31086.
19. Ammirati E, Cianflone D, Vecchio V et al. Effector memory T cells are associated with atherosclerosis in humans and animal models. J Am Heart Assoc 2012; 1: 27-41.
20. Baragetti A, Knoflach M, Cuccovillo I et al. Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population. Nutr Metab Cardiovasc Dis 2014; 24: 518-23.
21. Norata GD, Ongari M, Garlaschelli K et al. Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction. J Intern Med 2007; 262: 104-12.
22. Baragetti A, Norata GD, Sarcina C et al. High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease. J Intern Med 2013; 274: 252-62.
23. Giampaoli S, Palmieri L, Chiodini P et al. The global cardiovascular risk chart. Ital Heart J Suppl 2004; 5: 177-85.
24. Basevi V, Di Mario S, Morciano C, Nonino F, Magrini N. Comment on: American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011; 34(Suppl. 1): S11-61. Diabetes Care 2011; 34: e53; author reply e4.
25. Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-219.
26. Norata GD, Raselli S, Grigore L et al. Small dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cells. Atherosclerosis 2009; 206: 556-62.
27. Ammirati E, Bozzolo EP, Contri R et al. Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus. Nutr Metab Cardiovasc Dis 2014; 24: 751-9.
28. Stein JH, Korcarz CE, Hurst RT et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008; 21: 93-111; quiz 89-90.
29. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
30. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30: e47.
31. Salpea KD, Nicaud V, Tiret L, Talmud PJ, Humphries SE. The association of telomere length with paternal history of premature myocardial infarction in the European Atherosclerosis Research Study II. J Mol Med (Berl) 2008; 86: 815-24.
32. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-43.
33. Willeit P, Willeit J, Brandstatter A et al. Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler Thromb Vasc Biol 2010; 30: 1649-56.
34. Ye S, Shaffer JA, Kang MS et al. Relation between leukocyte telomere length and incident coronary heart disease events (from the 1995 Canadian Nova Scotia Health Survey). Am J Cardiol 2013; 111: 962-7.
35. Weischer M, Bojesen SE, Cawthon RM, Freiberg JJ, Tybjaerg-Hansen A, Nordestgaard BG. Short telomere length, myocardial infarction, ischemic heart disease, and early death. Arterioscler Thromb Vasc Biol 2012; 32: 822-9.
36. Nilsson PM, Tufvesson H, Leosdottir M, Melander O. Telomeres and cardiovascular disease risk: an update 2013. Transl Res 2013; 162: 371-80.
37. Barrett EL, Richardson DS. Sex differences in telomeres and lifespan. Aging Cell 2011; 10: 913-21.
38. Kyo S, Takakura M, Kanaya T et al. Estrogen activates telomerase. Cancer Res 1999; 59: 5917-21.
39. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000; 407: 538-41.
40. Sengupta S, Wasylyk B. Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors. Ann N Y Acad Sci 2004; 1024: 54-71.
41. Nordfjall K, Svenson U, Norrback KF, Adolfsson R, Lenner P, Roos G. The individual blood cell telomere attrition rate is telomere length dependent. PLoS Genet 2009; 5: e1000375.
42. Farzaneh-Far R, Lin J, Epel E, Lapham K, Blackburn E, Whooley MA. Telomere length trajectory and its determinants in persons with coronary artery disease: longitudinal findings from the heart and soul study. PLoS ONE 2010; 5: e8612.
43. Ehrlenbach S, Willeit P, Kiechl S et al. Influences on the reduction of relative telomere length over 10 years in the population-based Bruneck Study: introduction of a well-controlled high-throughput assay. Int J Epidemiol 2009; 38: 1725-34.
44. Weischer M, Bojesen SE, Nordestgaard BG. Telomere shortening unrelated to smoking, body weight, physical activity, and alcohol intake: 4, 576 general population individuals with repeat measurements 10 years apart. PLoS Genet 2014; 10: e1004191.
45. Teixeira MT, Arneric M, Sperisen P, Lingner J. Telomere length homeostasis is achieved via a switch between telomerase- extendible and -nonextendible states. Cell 2004; 117: 323-35.
46. Hemann MT, Strong MA, Hao LY, Greider CW. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001; 107: 67-77.
47. Bodnar AG, Ouellette M, Frolkis M et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279: 349-52.
48. Matthews C, Gorenne I, Scott S et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res 2006; 99: 156-64.
49. Steenstrup T, Hjelmborg JV, Kark JD, Christensen K, Aviv A. The telomere lengthening conundrum-artifact or biology? Nucleic Acids Res 2013; 41: e131.
50. Wilson WR, Herbert KE, Mistry Y et al. Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease. Eur Heart J 2008; 29: 2689-94.